Prioritizing genes associated with prostate cancer development

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Gorlov, Ivan P ^a   Sircar, Kanishka ^a   Zhao, Hongya ^a,b   Maity, Sankar N ^a   Navone, Nora M ^a   Gorlova, Olga Y ^a   Troncoso, Patricia ^a   Pettaway, Curtis A ^a   Byun, Jin Y ^a   Logothetis, Christopher J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AURORA A KINASE; CAVEOLIN 1; CONNECTIVE TISSUE GROWTH FACTOR; CYCLIN A2; CYCLIN DEPENDENT KINASE 1; EARLY GROWTH RESPONSE FACTOR 1; MONOCYTE CHEMOTACTIC PROTEIN 1; SERUM RESPONSE FACTOR; SMAD4 PROTEIN; SOMATOMEDIN C;

ARTICLE; BONE METASTASIS; BREAST CANCER; CANCER GROWTH; CARCINOGENESIS; CELL ADHESION; CELL MOTILITY; COMPUTER MODEL; CYTOSKELETON; EXTRACELLULAR MATRIX; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ASSOCIATION; HUMAN; LUNG CANCER; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTEIN PROTEIN INTERACTION; RELIABILITY; SCORING SYSTEM; VALIDATION PROCESS; ALGORITHM; BONE TUMOR; MALE; META ANALYSIS; METABOLISM; METASTASIS; PATHOLOGY; PHENOTYPE; PROSTATE TUMOR; STATISTICAL MODEL;

ALGORITHMS; BONE NEOPLASMS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MODELS, STATISTICAL; NEOPLASM METASTASIS; PHENOTYPE; PROSTATIC NEOPLASMS;

EID: 77958613785     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-599     Document Type: Article

References (25)

1. Shen L, Tan EC. Dimension reduction-based penalized logistic regression for cancer classification using microarray data. IEEE/ACM Trans Comput Biol Bioinform 2005, 2:166-175. 10.1109/TCBB.2005.22, 17044181.
2. Wang L, Zhu JS, Song MQ, Chen GQ, Chen JL. Comparison of gene expression profiles between primary tumor and metastatic lesions in gastric cancer patients using laser microdissection and cDNA microarray. World J Gastroenterol 2006, 12:6949-6954.
3. Zigeuner R, Droschl N, Tauber V, Rehak P, Langner C. Biologic significance of fascin expression in clear cell renal cell carcinoma: systematic analysis of primary and metastatic tumor tissues using a tissue microarray technique. Urology 2006, 68:518-522. 10.1016/j.urology.2006.03.032, 16979727.
4. Jansen MP, Foekens JA, Klijn JG, Berns EM. Re: Limits of predictive models using microarray data for breast cancer clinical treatment outcome [comment]. J Natl Cancer Inst 2005, 97:1851-1853. 10.1093/jnci/dji433, 16368948.
5. Reid JF, Lusa L, De Cecco L, Coradini D, Veneroni S, Daidone MG, Gariboldi M, Pierotti MA. Limits of predictive models using microarray data for breast cancer clinical treatment outcome. J Natl Cancer Inst 2005, 97:927-930. 10.1093/jnci/dji153, 15956654.
6. Habeck M. DNA microarray technology to revolutionise cancer treatment. Lancet Oncol 2001, 2:5. 10.1016/S1470-2045(00)00206-0, 11905621.
7. Gevaert O, De Smet F, Timmerman D, Moreau Y, De Moor B. Predicting the prognosis of breast cancer by integrating clinical and microarray data with Bayesian networks. Bioinformatics 2006, 22:e184-e190. 10.1093/bioinformatics/btl230, 16873470.
8. Brennan DJ, O'Brien SL, Fagan A, Culhane AC, Higgins DG, Duffy MJ, Gallagher WM. Application of DNA microarray technology in determining breast cancer prognosis and therapeutic response. Expert Opin Biol Ther 2005, 5:1069-1083. 10.1517/14712598.5.8.1069, 16050784.
9. Dolled-Filhart M, Camp RL, Kowalski DP, Smith BL, Rimm DL. Tissue microarray analysis of signal transducers and activators of transcription 3 (Stat3) and phospho-Stat3 (Tyr705) in node-negative breast cancer shows nuclear localization is associated with a better prognosis. Clin Cancer Res 2003, 9:594-600.
10. Barrett T, Troup DB, Wilhite SE, Ledoux P, Rudnev D, Evangelista C, Kim IF, Soboleva A, Tomashevsky M, Edgar R. NCBI GEO: mining tens of millions of expression profiles--database and tools update. Nucleic Acids Res 2007, 35(Database issue):D760-D765. 10.1093/nar/gkl887, 1669752, 17099226.
11. Edgar R, Domrachev M, Lash AE. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 2002, 30:207-210. 10.1093/nar/30.1.207, 99122, 11752295.
12. Gur-Dedeoglu B, Konu O, Kir S, Ozturk AR, Bozkurt B, Ergul G, Yulug IG. A resampling-based meta-analysis for detection of differential gene expression in breast cancer. BMC Cancer 2008, 8:396. 10.1186/1471-2407-8-396, 2631593, 19116033.
13. Lin R, Dai S, Irwin RD, Heinloth AN, Boorman GA, Li L. Gene set enrichment analysis for non-monotone association and multiple experimental categories. BMC Bioinformatics 2008, 9:481. 10.1186/1471-2105-9-481, 2636811, 19014579.
14. Ochsner SA, Steffen DL, Hilsenbeck SG, Chen ES, Watkins C, McKenna NJ. GEMS (Gene Expression MetaSignatures), a Web resource for querying meta-analysis of expression microarray datasets: 17β-estradiol in MCF-7 cells. Cancer Res 2009, 69:23-26. 10.1158/0008-5472.CAN-08-3492, 2782370, 19117983.
15. Rosenthal R. The file drawer problem and tolerance for null results. Psychol Bull 1979, 86:638-641.
16. Dennis G, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 2003, 4:P3. 10.1186/gb-2003-4-5-p3, 12734009.
17. Gorlov IP, Byun J, Gorlova OY, Aparicio AM, Efstathiou E, Logothetis CJ. Candidate pathways and genes for prostate cancer: a meta-analysis of gene expression data. BMC Med Genomics 2009, 2:48. 10.1186/1755-8794-2-48, 2731785, 19653896.
18. Byun J, Logothetis CJ, Gorlov IP. Housekeeping genes in prostate tumorigenesis. Int J Cancer 2009, 125:2603-2608. 10.1002/ijc.24680, 19551858.
19. Yue P, Melamud E, Moult J. SNPs3D: candidate gene and SNP selection for association studies. BMC Bioinformatics 2006, 7:166. 10.1186/1471-2105-7-166, 1435944, 16551372.
20. Chandran UR, Ma C, Dhir R, Bisceglia M, Lyons-Weiler M, Liang W, Michalopoulos G, Becich M, Monzon FA. Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic process. BMC Cancer 2007, 7:64. 10.1186/1471-2407-7-64, 1865555, 17430594.
21. Stanbrough M, Bubley GJ, Ross K, Golub TR, Rubin MA, Penning TM, Febbo PG, Balk SP. Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer. Cancer Res 2006, 66:2815-2825. 10.1158/0008-5472.CAN-05-4000, 16510604.
22. Price ND, Trent J, El-Naggar AK, Cogdell D, Taylor E, Hunt KK, Pollock RE, Hood L, Shmulevich I, Zhang W. Highly accurate two-gene classifier for differentiating gastrointestinal stromal tumors and leiomyosarcomas. Proc Natl Acad Sci USA 2007, 104:3414-3419. 10.1073/pnas.0611373104, 1805517, 17360660.
23. Yang YH, Dudoit S, Luu P, Lin DM, Peng V, Ngai J, Speed TP. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res 2002, 30:e15. 10.1093/nar/30.4.e15, 100354, 11842121.
24. Nakagawa T, Kollmeyer TM, Morlan BW, Anderson SK, Bergstralh EJ, Davis BJ, Asmann YW, Klee GG, Ballman KV, Jenkins RB. A tissue biomarker panel predicting systemic progression after PSA recurrence post-definitive prostate cancer therapy. PLoS One 2008, 3:e2318. 10.1371/journal.pone.0002318, 2565588, 18846227.
25. Nikitin A, Egorov S, Daraselia N, Mazo I. Pathway studio--the analysis and navigation of molecular networks. Bioinformatics 2003, 19:2155-2157. 10.1093/bioinformatics/btg290, 14594725.